Fish Oil Taken After AV Graft Creation Beneficial

Share this article:

Fish oil supplementation is associated with cardiovascular benefits in patients with stage 5 chronic kidney disease following creation of a synthetic arteriovenous graft for hemodialysis access, according to study findings published in the Journal of the American Medical Association (2012;307:1809-1816).

In the study, 99 patients took four 1 gram capsules of fish oil and 97 took placebo on the seventh day following graft creation. After 12 months, compared with the placebo group, the fish-oil group experienced a lower rate of graft failure (3.43 vs. 5.95 per 1,000 access-days), half as many thromboses (1.71 vs. 3.41 per 1,000 access-days), fewer corrective interventions (2.89 vs. 4.92 per 1,000 access-days), improved cardiovascular-event-free survival, and lower mean systolic blood pressure. Loss of native patency did not differ significantly between the groups, however.

Share this article:
You must be a registered member of RUN to post a comment.

Next Article in News in Brief

More in News in Brief

AVF Placement Less Likely in Metropolitan Areas

Rates of AVF placement in patients approaching HD in the US are significantly lower in metropolitan areas.

ESA Resistance Found To Increase Mortality

Greater resistance to ESA is associated with an increased risk of death among patients on chronic HD.

Overactive Bladder Found to Raise Nocturia Risk

Overactive Bladder Found to Raise Nocturia Risk

In a study, severe nocturia predicted increased mortality risk.